Point-of-Care Tests for Bladder Cancer: The Influencing Role of Hematuria
Introduction. Several point-of-care tests (POCT) are available for the diagnosis of bladder cancer (BC). We evaluate the impact of HU (hematuria) on performance of POCTs. Materials and Methods. Urine from 10 donors was diluted with blood from 0.5 to 0.00625%. BladderCheckR, BTAstatR, BCMR, and BTAR...
Saved in:
| Main Authors: | Joerg Hennenlotter, Severine Huber, Tilman Todenhöfer, Ursula Kuehs, David Schilling, Stefan Aufderklamm, Georgios Gakis, Christian Schwentner, Arnulf Stenzl |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | Advances in Urology |
| Online Access: | http://dx.doi.org/10.1155/2011/937561 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Circulating and Disseminated Tumor Cells in the Management of Advanced Prostate Cancer
by: Stephan Kruck, et al.
Published: (2012-01-01) -
A rare cause for hematuria: Lymphoma of the urinary bladder
by: Sherin P Mathew, et al.
Published: (2020-01-01) -
Moderate degradation does not preclude microarray analysis of small amounts of RNA
by: Oliver Schoor, et al.
Published: (2003-12-01) -
Clinical Utility of Bladder Cancer Biomarkers
by: Laura Maria Krabbe, Georgios Gakis, Yair Lotan
Published: (2020-10-01) -
Exercise-Induced Hematuria as the Main Manifestation of Migration of Intrauterine Contraceptive Device into the Bladder
by: Michel Platiny Mascarenhas, et al.
Published: (2012-01-01)